top of page

Knowledge Center

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Patient Stories

Personalizing Metastatic Breast Cancer Treatment Through Liquid Biopsy | Dr. Shane Dormady

Patient Stories

Jun 11, 2026

Personalizing Metastatic Breast Cancer Treatment Through Liquid Biopsy | Dr. Shane Dormady

Read More
Personalizing Metastatic Breast Cancer Treatment Through Liquid Biopsy | Dr. Shane Dormady
The Emerging Role of Clonal Hematopoiesis in Personalized Risk Evaluation | Dr. Raj Patel

Patient Stories

Jun 2, 2026

The Emerging Role of Clonal Hematopoiesis in Personalized Risk Evaluation | Dr. Raj Patel

Read More
The Emerging Role of Clonal Hematopoiesis in Personalized Risk Evaluation | Dr. Raj Patel
Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Patient Stories

Dec 19, 2025

Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Read More
Advancing Targeted Cancer Therapy Selection Through Liquid Biopsy | Dr. Gilberto Lopes

Publications

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Publications

Dec 1, 2025

Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study

Read More
Clinical utility of cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) next generation sequencing (NGS) for diagnosis and treatment of leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC): a multi-centre retrospective study
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Publications

Nov 13, 2025

High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population

Read More
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

Publications

Nov 12, 2025

Predictive Model for Mortality Risk
Stratification Using Laboratory
Biomarkers in Singaporeans

Read More
Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

Clinical Insights

Why Don't We Routinely Screen for More Cancers?

Article

August 5, 2026

Why Don't We Routinely Screen for More Cancers?

Read More
Why Don't We Routinely Screen for More Cancers?
The Right Signal at the Right Time: Liquid Biopsy Trends From ASCO 2026

Article

July 22, 2026

The Right Signal at the Right Time: Liquid Biopsy Trends From ASCO 2026

Read More
The Right Signal at the Right Time: Liquid Biopsy Trends From ASCO 2026
MCED Tests: Promise, Limitations, and 3 Questions Worth Asking

Article

July 8, 2026

MCED Tests: Promise, Limitations, and 3 Questions Worth Asking

Read More
MCED Tests: Promise, Limitations, and 3 Questions Worth Asking
Why Cancer Prevention Begins With Longevity Medicine

Article

July 1, 2026

Why Cancer Prevention Begins With Longevity Medicine

Read More
Why Cancer Prevention Begins With Longevity Medicine
Cancer Risk Testing vs. Cancer Screening: What's the Difference?

Article

June 24, 2026

Cancer Risk Testing vs. Cancer Screening: What's the Difference?

Read More
Cancer Risk Testing vs. Cancer Screening: What's the Difference?
Clonal Hematopoiesis: The Somatic Risk Factor Hiding in Plain Sight

Article

June 17, 2026

Clonal Hematopoiesis: The Somatic Risk Factor Hiding in Plain Sight

Read More
Clonal Hematopoiesis: The Somatic Risk Factor Hiding in Plain Sight
When the Scan is Clear: How MRD is Changing Cancer Surveillance After Treatment

Article

June 10, 2026

When the Scan is Clear: How MRD is Changing Cancer Surveillance After Treatment

Read More
When the Scan is Clear: How MRD is Changing Cancer Surveillance After Treatment
When ctDNA Falls Short: The Case for ctRNA in Liquid Biopsy

Article

June 3, 2026

When ctDNA Falls Short: The Case for ctRNA in Liquid Biopsy

Read More
When ctDNA Falls Short: The Case for ctRNA in Liquid Biopsy
Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Article

May 26, 2026

Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid

Read More
Unlocking Treatment Options for Brain Cancers Using Cerebrospinal Fluid
Why “Early Detection” Is Not the Same as “Screening”

Article

May 19, 2026

Why “Early Detection” Is Not the Same as “Screening”

Read More
Why “Early Detection” Is Not the Same as “Screening”

News & Updates

Singapore Research and Innovation Moves from Aging Study to Real-World Health Assessment

News & Updates

Aug 11, 2026

Singapore Research and Innovation Moves from Aging Study to Real-World Health Assessment

Read More
Add
Singaporeans are living longer, but are they living better?

News & Updates

Aug 11, 2026

Singaporeans are living longer, but are they living better?

Read More
Add
Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

News & Updates

Mar 18, 2026

Why Dr Eric Topol Calls CHIP a Primary Cardiovascular Risk Driver

Read More
Add

Webinars

Clinical Perspectives on Liquid Biopsy in Cerebrospinal Fluid for Advanced Lung Cancer

Webinars

Aug 3, 2026

Clinical Perspectives on Liquid Biopsy in Cerebrospinal Fluid for Advanced Lung Cancer

Read More
Clinical Perspectives on Liquid Biopsy in Cerebrospinal Fluid for Advanced Lung Cancer
Mayo Clinic Laboratories: The next generation of liquid biopsy testing

Webinars

Nov 12, 2025

Mayo Clinic Laboratories: The next generation of liquid biopsy testing

Visit
Mayo Clinic Laboratories: The next generation of liquid biopsy testing
New Frontiers in Liquid Biopsy for Lung Cancer

Webinars

Jun 30, 2021

New Frontiers in Liquid Biopsy for Lung Cancer

Read More
New Frontiers in Liquid Biopsy for Lung Cancer

Case Studies

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Case Studies

Nov 12, 2025

LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer

Read More
LiquidHALLMARK® ctRNA Detects ALK Fusion in Lung Cancer
bottom of page